Anika Therapeutics Inc (ANIK)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ANIK market cap is 228.03M. The company's latest EPS is USD -5.6445 and P/E is -2.77.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.47M | 42.97M | 40.52M | 41.92M | 38.75M |
| Operating Income | -7.67M | -63.78M | -5.06M | 161k | -28.02M |
| Net Income | -6.58M | -63M | -4.51M | -88k | -29.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 114.61M | 159.12M | 168.89M | 156.24M | 166.66M |
| Operating Income | 34.25M | -28.32M | 2.62M | -19.4M | -87.64M |
| Net Income | 27.19M | -23.98M | 4.13M | -14.86M | -82.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 328.16M | 270.63M | 263.74M | 262.66M | 231.41M |
| Total Liabilities | 57.67M | 58.37M | 55.21M | 52.32M | 51.54M |
| Total Equity | 270.49M | 212.27M | 208.54M | 210.34M | 179.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 330.71M | 365.61M | 347.54M | 349.13M | 270.63M |
| Total Liabilities | 42.33M | 93.21M | 60.45M | 63.57M | 58.37M |
| Total Equity | 288.38M | 272.4M | 287.09M | 285.56M | 212.27M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.43M | -1.79M | -126k | -1.2M | 3.82M |
| Investing | -3.59M | -5.43M | -1.81M | -5.21M | -7.03M |
| Financing | -6.67M | -6.32M | -2.27M | -3.38M | -7.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 37.01M | 13.07M | 8.4M | 4.41M | -1.79M |
| Investing | 39.69M | -71.26M | -3.12M | -7.49M | -5.43M |
| Financing | -8.14M | -3.77M | -6.78M | -4.85M | -6.32M |
| Market Cap | 228.03M |
| Price to Earnings Ratio | -2.77 |
| Price to Sales Ratio | 1.37 |
| Price to Cash Ratio | 3.14 |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 14.65M |
| Average Volume (1 week) | 70.65k |
| Average Volume (1 Month) | 76.8k |
| 52 Week Change | -30.71% |
| 52 Week High | 29.115 |
| 52 Week Low | 15.48 |
| Spread (Intraday) | 3.67 (22.31%) |
| Company Name | Anika Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://anika.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
